Dachaigh › Multiple Sclerosis Ath-thionndaidh is Lùghdachadh
Sgrùdaidhean clionaigeach Multiple Sclerosis Ath-thionndaidh is Lùghdachadh a’ fastadh anns na SA
Tha 18 sgrùdaidhean airson Multiple Sclerosis Ath-thionndaidh is Lùghdachadh a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
- California6 sgrùdaidhean
- Georgia3 sgrùdaidhean
- Illinois6 sgrùdaidhean
- Texas4 sgrùdaidhean
- Wisconsin3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
A’ fastadhÌre 3
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
A’ fastadhÌre 3
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
A’ fastadh
Aoisean 22 gu 60 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06796504Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
A’ fastadhSgrùdadh amharc
Aoisean 40 gu 70 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07758270Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06864936Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
A’ fastadhÌre 1/2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05359653Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
A’ fastadh
Aoisean 45 gu 89 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06919900Intermittent Hypoxia in Persons With Multiple Sclerosis
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT06276634Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT07225361Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
A’ fastadh
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 6 Màrt 2026 · NCT07376772Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 23 Gearr 2026 · NCT06390930Effects of Ublituximab on Motor Functions in Multiple Sclerosis
A’ fastadhÌre 1 tràth
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 9 Gearr 2026 · NCT06629428Home Based Functional Balance Intervention for Multiple Sclerosis
A’ fastadh
Aoisean 40 gu 90 · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT07355387"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Dàmh 2025 · NCT07222618Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
A’ fastadh
Aoisean 22 gu 75 · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT05964829MS-ResearchBiomarkerS
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallainA’ toirt iomradh air pàigheadh do chom-pàirtichean
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2024 · NCT05204459Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 6 Ògmh 2022 · NCT04458688Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.